Oxidative Stress in Lung Diseases : Volume 2

個数：

Oxidative Stress in Lung Diseases : Volume 2

Chakraborti, Sajal (EDT)/ Parinandi, Narasimham L. (EDT)/ Ghosh, Rita (EDT)

ウェブストア価格 ¥45,532（本体¥41,393）
Springer Verlag, Singapore（2021/01発売）
外貨定価 US$ 219.99
ポイント 413pt

提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
【重要ご説明事項】
1. 納期遅延や、ご入手不能となる場合が若干ございます。
2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
3. 美品のご指定は承りかねます。

●3Dセキュア導入とクレジットカードによるお支払いについて

【入荷遅延について】
世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。

◆画像の表紙や帯等は実物とは異なる場合があります。

◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
また、洋書販売価格は、ご注文確定時点での日本円価格となります。
ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。

製本 Paperback:紙装版/ペーパーバック版／ページ数 488 p.
言語 ENG
商品コード 9789813293687
DDC分類 571.9453

Full Description

This is the second volume of the comprehensive, two-volume work on oxidative stress in lung diseases. Adopting a multidisciplinary approach, it demonstrates the cellular and molecular mechanisms associated with ROS (reactive oxygen species)-induced initiation and progression of a variety of lung diseases, such as COPD, emphysema, asthma, cystic fibrosis, occupational pulmonary diseases and pulmonary hypertension and discusses points for therapeutic intervention. The book also covers translational research and the latest research on prevention and therapeutics. Each chapter includes in-depth insights into the mechanisms associated with lung diseases and into identifying targets for drug development. Bridging the gap between fundamental and translational research, and examining applications in the biomedical and pharmaceutical industry, it is a thought- provoking read for basic and applied scientists engaged in biomedical research.

Part A.- Chapter 1. The effects of oxidative stress on the pulmonary surfactant and the role of lipids in this scenario.- Chapter 2. Oxidative stress in experimental models of acute lung injury.- Chapter 3. Potential of mesenchymal stem cells in modulating oxidative stress in the management of lung diseases.- Chapter 4. Role of NADPH oxidase induced oxidative stress in matrix metalloprotease-mediated lung diseases.- Chapter 5. Oxidative stress mechanisms in the pathogenesis of environmental lung diseases.- Part B.- Chapter 6. Oxidative stress induced mitochondrial dysfunction and asthma.- Chapter 7. Regulation of antioxidant Nrf2 signaling, an important pathway in COPD.- Chapter 8. Role of smoke-induced oxidative stress in pathogenesis of chronic obstructive pulmonary disease.- Chapter 9. Oxidative stress in obstructive and restrictive lung diseases.- Chapter 10. The use of ozone as redox modulator in the treatment of the chronic obstructive pulmonary disease.- Chapter 11. TRP channels, oxidative stress and chronic obstructive pulmonary disease.- Chapter 12. Paraquat induced oxidative stress and lung inflammation.- Chapter 13. Environmental, occupational and cancer drug induced oxidative stress in lung fibrosis.- Part C.- Chapter 14. Respiratory syncytial virus-induced oxidative stress in lung pathogenesis.- Chapter 15. Reactive oxygen species: Friends or foes of lung cancer?.- Chapter 16. Roles of long non-coding RNAs in lung cancer.- Chapter 17. modulator of therapeutic response in non small cell lung carcinoma.- Chapter 18. old story, new modalities!.Part D.- Chapter 19. Oxidative stress and therapeutic development in lung cancer.- Chapter 20. Regulation of oxidative stress by nitric oxide defines lung development and Diseases.- Chapter 21. Epidermal growth factor receptor: promising targets for non-small cell lung cancer.- Chapter 22. Oxygenated lipid products in COPD and asthma: a clinical picture.